Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Annette Schmitt-Graeff"'
Autor:
Tamina Rückert, Geoffroy Andrieux, Melanie Boerries, Kathrin Hanke-Müller, Nadine M. Woessner, Stephanie Doetsch, Christoph Schell, Konrad Aumann, Julia Kolter, Annette Schmitt-Graeff, Marcel Schiff, Lukas M. Braun, Eileen Haring, Sandra Kissel, Benjamin A. Siranosian, Ami S. Bhatt, Peter Nordkild, Jan Wehkamp, Benjamin A. H. Jensen, Susana Minguet, Justus Duyster, Robert Zeiser, Natalie Köhler
Publikováno v:
Science translational medicine. 14(676)
Acute graft-versus-host disease (aGVHD), which is driven by allogeneic T cells, has a high mortality rate and limited treatment options. Human β-defensin 2 (hBD-2) is an endogenous epithelial cell–derived host-defense peptide. In addition to its a
Autor:
Sebastian Halbach, Marina Kreutz, Joy Edwards-Hicks, Melanie Boerries, Justus Duyster, Jörg Büscher, Tobias Madl, Olaf Groß, Sandra Duquesne, David O’Sullivan, Eileen Haring, Wolfgang Melchinger, Gesa Richter, Petya Apostolova, Tilman Brummer, Michael Lübbert, Erika L. Pearce, Franziska M. Uhl, Barbara Sauer, Sophia Chen, Bruce R. Blazar, Geoffroy Andrieux, Robert Zeiser, Annette Schmitt-Graeff, Khalid Shoumariyeh
Publikováno v:
Sci Transl Med
Science translational medicine : integrating medicine and science / American Association for the Advancement of Science
Science translational medicine : integrating medicine and science / American Association for the Advancement of Science
Acute myeloid leukemia (AML) relapse after allogeneic hematopoietic cell transplantation (allo-HCT) has a dismal prognosis. We found that T cells of patients relapsing with AML after allo-HCT exhibited reduced glycolysis and interferon-γ production.
Autor:
Khalid Shoumariyeh, Robert Zeiser, Sivahari P. Gorantla, Sebastian Halbach, Frederike A. Hartl, Alica J. Emhardt, Julius Wehrle, Jonas S. Jutzi, Sebastian Fuchs, Ioanna Triviai, Sandra Duquesne, Michael Hettich, Annette Schmitt-Graeff, Eliana Ruggiero, Susana Minguet, Wolfgang Melchinger, Jürgen Finke, Chiara Bonini, Nicolaus Kröger, Pia Veratti, Anna Lena Illert, Bruce R. Blazar, Melanie Boerries, Mark Bartholomä, Teresa Poggio, Geoffrey R. Hill, Steven W. Lane, Gabriele Niedermann, Petya Apostolova, Slavica Vuckovic, Nikolas von Bubnoff, Konrad Aumann, Hauke Busch, Stephan Ehl, Florian H. Heidel, Sandra Pennisi, Dietmar Pfeifer, Justus Duyster, Cornelius Miething, David O’Sullivan, Marie Follo, Lukas Braun, Christine Dierks, Heiko Becker, Heike L. Pahl, Jan Rohr, Tilman Brummer, Alessandro Prestipino, Erika L. Pearce
Publikováno v:
Science Translational Medicine
Science translational medicine : integrating medicine and science / American Association for the Advancement of Science
Science translational medicine : integrating medicine and science / American Association for the Advancement of Science
Recent evidence has revealed that oncogenic mutations may confer immune escape. A better understanding of how an oncogenic mutation affects immunosuppressive programmed death ligand 1 (PD-L1) expression may help in developing new therapeutic strategi
Autor:
Alessandro, Prestipino, Alica J, Emhardt, Konrad, Aumann, David, O'Sullivan, Sivahari P, Gorantla, Sandra, Duquesne, Wolfgang, Melchinger, Lukas, Braun, Slavica, Vuckovic, Melanie, Boerries, Hauke, Busch, Sebastian, Halbach, Sandra, Pennisi, Teresa, Poggio, Petya, Apostolova, Pia, Veratti, Michael, Hettich, Gabriele, Niedermann, Mark, Bartholomä, Khalid, Shoumariyeh, Jonas S, Jutzi, Julius, Wehrle, Christine, Dierks, Heiko, Becker, Annette, Schmitt-Graeff, Marie, Follo, Dietmar, Pfeifer, Jan, Rohr, Sebastian, Fuchs, Stephan, Ehl, Frederike A, Hartl, Susana, Minguet, Cornelius, Miething, Florian H, Heidel, Nicolaus, Kröger, Ioanna, Triviai, Tilman, Brummer, Jürgen, Finke, Anna L, Illert, Eliana, Ruggiero, Chiara, Bonini, Justus, Duyster, Heike L, Pahl, Steven W, Lane, Geoffrey R, Hill, Bruce R, Blazar, Nikolas, von Bubnoff, Erika L, Pearce, Robert, Zeiser
Publikováno v:
Science translational medicine. 10(429)
Recent evidence has revealed that oncogenic mutations may confer immune escape. A better understanding of how an oncogenic mutation affects immunosuppressive PD-L1 expression may help in developing new therapeutic strategies. Here, we show that oncog